|
Market Cap (3-Jul) $23,106,150 (942nd) |
Close (13-Jun) $0.009 |
Volume (13-Jun) 0 |
Shortsold (8-Jun) 1,624,075 (0.07%) (501st) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.02 |
A news article has been posted about Creso Pharma on the AFR. The article was published around , on 16 November 2021 at 4:56pm.
A $160 million cannabis products company is understood to be at the heart of ASIC’s interest in Sydney stockbroker EverBlu Capital. EverBlu executive chairman, Adam Blumenthal, doubles as non-executive chairman and co-founder at ASX-listed Creso Pharma.
Read ArticleCPH was $0.123 at the close of trade on 16 November 2021
| Recent Articles about ASX:CPH | |
|---|---|
| 6-Dec | Significant progress with HOPE® program; Zelira poised for IND ...
company-announcements.afr.com |
| 12-Oct | Stockhead | Stockhead | Herald Sun
heraldsun.com.au |
| 8-Oct | Stockhead | Stockhead | Herald Sun
heraldsun.com.au |
| 22-Aug | Stockhead | Stockhead | Herald Sun
heraldsun.com.au |
| 15-Aug | Stockhead | Stockhead | Herald Sun
heraldsun.com.au |
| 30-Jul | Stockhead | Stockhead | Herald Sun
heraldsun.com.au |
| 26-Jul | Melodiol Global Health Ltd ME1
morningstar.com |
| 24-Jul | Melodiol Global Health Limited (ASX: ME1) - Share Price and Research
intelligentinvestor.com.au |
| 23-Jul | Closing Bell: Tuesday wins what Monday lost on the ASX
msn.com |
| 24-Jun | Nothing Found
stockhead.com.au |
| Tracked |
Find all articles about Creso Pharma, including others on the AFR, on the media page.
You must be logged in to post a reply.
Creso Pharma 